Helicobacter

Papers
(The TQCC of Helicobacter is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
A real‐world exploratory study on the feasibility of vonoprazan and tetracycline dual therapy for the treatment of Helicobacter pylori infection in special populations with penicillin allergy o63
DNA starvation/stationary phase protection protein of Helicobacter pylori as a potential immunodominant antigen for infection detection53
Gastric Helicobacter pylori infection does not contribute to extraoral halitosis and its eradication cannot achieve substantial reduction of halitosis50
Issue Information43
Second‐ and Third‐Line Therapies for Helicobacter pylori Eradication in Slovenia: Data From 2013–2023 of the European Registry on 40
A “new” option in Helicobacter pylori eradication: High‐dose amoxicillin dual therapy outperforms bismuth quadruple therapy in a high dual resistance setting40
Optimal Duration of Bismuth‐Containing Quadruple Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta‐Analysis40
UreBimmunodominant epitope‐specificCD8+T‐cell responses were beneficial in reducing gastric symptoms inHelicobacter pylori‐infected individuals40
Proteomic Profiling of Extracellular Vesicles Reveals Potential Biomarkers for Helicobacter pylori Infection and Gastric Cancer37
Tegoprazan‐Amoxicillin Dual Therapy for Helicobacter pylori Eradication: A Prospective, Randomized, Multicenter Study in Fujian, China35
Efficacy and safety of minocycline quadruple therapy for Helicobacter pylori eradication: A meta‐analysis of RCTs35
Low‐dose or high‐dose amoxicillin in vonoprazan‐based dual therapy for Helicobacter pylori eradication? A systematic review and meta‐analysis35
33
Seroprevalence of Helicobacter pylori infection among schoolchildren in southern Taiwan—A 20‐year longitudinal follow‐up33
Indications of Helicobacter pylori Eradication Treatment and Its Influence on Prescriptions and Effectiveness (Hp‐EuReg)33
Issue Information31
Nationwide survey ofHelicobacter pyloriseropositivity and gastric atrophy in Zambia30
Low compliance to post‐screening recommendations in a family‐based Helicobacter pylori screening and treatment program: A prospective cohort study29
Managing Helicobacter pylori as an Infectious Disease: Implementation of Antimicrobial Stewardship29
Letter to the Editor regarding the article: “Forty years of Helicobacter pylori infection and changes in findings at esophagogastroduodenoscopy”29
Efficacy of Tegoprazan‐Containing Sequential Eradication Treatment Compared to Esomeprazole‐Containing Sequential Eradication of Helicobacter pylori in South Korea, a Region With High Antimicro29
Roles of Gastric Non‐Helicobacter pylori Helicobacter Species in Gastric Disease Development: A Review29
Droplet Digital PCR ‐Based Detection of Clarithromycin Resistance on Rapid Urease Test Samples Predicts 26
Prophylactic immunization to Helicobacter pylori infection using spore vectored vaccines25
Bismuth, esomeprazole, metronidazole and amoxicillin or tetracycline as a first‐line regimen for Helicobacter pylori eradication: A randomized controlled trial24
Issue Information23
Innate Immunity in Helicobacter pylori Infection and Gastric Oncogenesis23
Helicobacterspecies binding to the human gastric mucosa22
Efficacy of bismuth for antibiotic‐resistant Helicobacter pylori strains eradication: A systematic review and meta‐analysis21
Whole genome sequencing reveals novel genetic mutations of Helicobacter pylori associating with resistance to clarithromycin and levofloxacin21
Perspectives from recent advances of Helicobacter pylori vaccines research21
20
Cardia and non‐cardia gastric cancer risk associated with Helicobacter pylori in East Asia and the West: A systematic review, meta‐analysis, and estimation of population attributable fraction20
Efficacy of Bismuth Quadruple Therapy in the Treatment of Helicobacter pylori‐Infected Peptic Ulcer Children in Vietnam19
Effect of Helicobacter pylori infection and its eradication on the expression of tight junction proteins in the gastric epithelium in relation to gastric carcinogenesis19
Assessing the Capabilities of Novel Open‐Source Artificial Intelligence—DeepSeek in Helicobacter pylori‐Related Queries19
Development and Evaluation of a Multi‐Epitope Vaccine Based on P22 Virus‐Like Particles Targeting Helicobacter pylori19
Vonoprazan and amoxicillin dual therapy as the first‐line treatment of Helicobacter pylori infection: A systematic review and meta‐analysis19
Association between genetic polymorphisms of NOD1, Interleukin‐1B, and cagA strain with low‐grade duodenal eosinophilia in Helicobacter pylori‐related dyspepsia18
Helicobacter pylori infection prevalence in ambulatory settings in 2017–2019 in RUSSIA: The data of real‐world national multicenter trial18
Authors' Reply to the Letter on “Is Tailored Bismuth Quadruple Therapy (With Clarithromycin or Furazolidone) Based on Fecal Molecular Susceptibility Testing in First‐Line Helicobacter pylori Er18
Characterization of Fecal Microbial Communities in Patients With Type 2 Diabetes Mellitus Combined With Helicobacter pylori Infection18
Efficacy of Three Amoxicillin Doses in Vonoprazan Dual Therapy for Helicobacter pylori Eradication: A Randomized Noninferiority Trial18
Helicobacter pylori and Impaired Early Childhood Development—Evidence From a Birth Cohort Study From Ghana and Côte d'Ivoire17
Influences ofHelicobacter pyloriinfection on diversity, heterogeneity, and composition of human gastric microbiomes across stages of gastric cancer development17
Characteristics of phenotypic antibiotic resistance of Helicobacter pylori and its correlation with genotypic antibiotic resistance: A retrospective study in Ningxia17
Prevalence estimates of Helicobacter species infection in pancreatic and biliary tract cancers16
The expression and function of theB7family inHelicobacter pyloriinfection and gastric carcinogenesis process16
Disruption of the gastric epithelial barrier in Correa's cascade: Clinical evidence via confocal endomicroscopy16
Inquiry about methodology used to isolate multiple Helicobacter pylori strains from the same patient16
Helicobacter pylori infection found during upper endoscopy performed for the diagnosis of celiac, inflammatory bowel diseases, and eosinophilic esophagitis: A multicenter pediatric European stu15
GM‐CSF as a potential candidate of a vaccine‐induced reduction ofHelicobacter pyloriinfection15
Effect of Lactobacillus gasseriBIO6369 and Lacticaseibacillus rhamnosusBIO5326 on Gastric Carcinogenesis Induced by Helicobacter pylori Infection15
Molecular detection of Helicobacter pylori and its genotypic antimicrobial resistance patterns in dyspeptic Mozambican patients15
The Gastric Microbiota Invade the Lamina Propria in Helicobacter pylori ‐Associated Gastritis and Precancer15
Boosting the Anti‐Helicobacter Efficacy of Azithromycin through Natural Compounds: Insights From In Vitro, In Vivo, Histopathological, and Molecular Docking Investigations15
An Economic Evaluation of Family‐Based Versus Traditional Helicobacter pylori Screen‐and‐Treat Strategy: Based on Real‐World Data and Microsimulation Model15
Preventive effect of Helicobacter pylori eradication on the coronary heart diseases depending on age and sex with a median follow‐up of 51 months15
Prevalence of Helicobacter pylori infection among resettled refugees presenting to a family medicine clinic in the United States15
Age of eradication and failure rates of clarithromycin‐containing triple therapy forHelicobacter pylori: A 15‐year population‐based study14
Interpretation the Results of Eradicating Helicobacter pylori Infection Causing Colorectal Cancer Could Be Cautious14
Effects of prior antibiotic use on clarithromycin resistance in Helicobacter pylori14
Helicobacter bilis infection induces oxidative stress in and enhances the proliferation of human cholangiocytes13
Letter to the Editor: Efficacy of Lactobacillus spp. Supplementation in Helicobacter pylori Eradication: A Systematic Meta‐Analysis of Randomized Controlled Trials With Trial Sequential 13
Issue Information13
After 28 Years, Professor David Y. Graham Says Goodbye and Helicobacter Welcomes a New Editor13
Effect of Helicobacter pylori eradication on gastric precancerous lesions: A systematic review and meta‐analysis13
Evaluating the potency of zoliflodacin against Helicobacter pylori: In vitro activity and conserved GyrB target13
Antimicrobial screening involving Helicobacter pylori of nano‐therapeutic compounds based on the amoxicillin antibiotic drug12
Concentration‐dependent effect of amoxicillin against clinical strains of Helicobacter pylori12
Exploring the capacities of ChatGPT: A comprehensive evaluation of its accuracy and repeatability in addressing helicobacter pylori‐related queries12
 12
Antibiotic resistance patterns and therapeutic outcomes of pediatric Helicobacter pylori infection in a high‐migrant Singaporean cohort12
Urolithin B alleviates Helicobacter pylori‐induced inflammation and oxidative stress in mice12
The Interplay Between Helicobacter pylori and Suppressors of Cytokine Signaling (SOCS) Molecules in the Development of Gastric Cancer and Induction of Immune Response11
Gastric Cancer Endoscopic Screening in an Intermediate‐Risk Country—A Dual‐Center Pilot Program11
Influence of Helicobacter pylori infection on PD‐1/PD‐L1 blockade therapy needs more attention11
Dynamic changes in antibiotic resistance genes and gut microbiota afterHelicobacter pylorieradication therapies11
“True” Helicobacter pylori infection and non‐cardia gastric cancer: A pooled analysis within the Stomach Cancer Pooling (StoP) Project11
Persistent advanced periductal fibrosis is associated with cagA‐positive Helicobacter pylori infection in post‐praziquantel treatment of opisthorchiasis11
Correlation of FUT3 and FUT6 Gene Polymorphisms With Helicobacter pylori Infection11
Reply: Is Tailored Bismuth Quadruple Therapy (With Clarithromycin or Furazolidone) Based on Fecal Molecular Susceptibility Testing in First‐Line Helicobacter pylori Eradication Treatment More E11
Optimizing Duration and Dosing Frequency of Vonoprazan–Amoxicillin Dual Therapy for Helicobacter pylori: A Multicenter Randomized Trial11
Reevaluating the Adverse Events With the Same‐Dosage Regimen in Hemodialysis Patients Undergoing Helicobacter pylori Eradication11
Efficacy and Safety of Vonoprazan in Dual/Triple/Quadruple Regimens Both in First‐Line and Rescue Therapy for Helicobacter pylori Eradication: A Systematic Review With Meta‐Analysis11
11
Issue Information11
Persistent advanced periductal fibrosis is and helicobacter pylori infection in post‐treatment of opisthorchiasis: Correspondence10
Cost‐Effectiveness of Population‐Based Helicobacter pylori Screening With Eradication for Optimal Age of Implementation10
10
Empirical Therapy Versus Tailored Therapy of Helicobacter pylori in Korea: Results of the K‐CREATE Study10
Histopathologically defined intestinal metaplasia in lesser curvature of corpus prior to Helicobacter pylori eradication is a risk factor for gastric cancer development10
Advances in Helicobacter pylori vaccine research: From candidate antigens to adjuvants—A review10
Helicobacter hepaticus promotes liver fibrosis through oxidative stress induced by hydrogenase in BALB/c mice10
10
A 15‐year review of Helicobacter pylori screening and treatment among United States Veterans10
Resilience of the Gut Microbiome to Short Proton Pump Inhibitor Therapy With or Without High‐Dosage L. reuteri in H. pylori 10
Economic and health impacts of Helicobacter pylori eradication strategy for the treatment of peptic ulcer disease: A cost‐effectiveness analysis10
Helicobacter pylori infection and rheumatoid arthritis as risk enhancers' factors for atherosclerotic cardiovascular diseases9
Primary antibiotic resistance of Helicobacter pylori in India over the past two decades: A systematic review9
Research trends on vonoprazan‐based therapy for Helicobacter pylori eradication: A bibliometric analysis from 2015 to 20239
Current role of tailored therapy in treating Helicobacter pylori infections. A systematic review, meta‐analysis and critical analysis9
Interactions between Helicobacter pylori infection and host metabolic homeostasis: A comprehensive review9
Development of a modified ABC method among Helicobacter pylori infected but serum pepsinogen test‐negative individuals9
Helicobacter pyloriCagA Promotes the Formation of Gallstones by Increasing the Permeability of Gallbladder Epithelial Cells9
Helicobacter pylori‐positive chronic atrophic gastritis and cellular senescence9
0.60207200050354